The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention
Context: Elevated uric acid (UA) is seen in several vascular diseases. Its significance as a prognostic marker in patients undergoing percutaneous coronary intervention (PCI) is unknown. Aims: The aim of this study was to evaluate the association between elevated UA and major adverse cardiovascular...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Heart India |
| Subjects: | |
| Online Access: | http://www.heartindia.net/article.asp?issn=2321-449X;year=2022;volume=10;issue=2;spage=74;epage=79;aulast=Naim |
| _version_ | 1811275774852857856 |
|---|---|
| author | Anjum Naim Ashish Jha Amresh Kumar Singh Bhuwan Chandra Tiwari Sudarshan K Vijay Naveen Jamwal |
| author_facet | Anjum Naim Ashish Jha Amresh Kumar Singh Bhuwan Chandra Tiwari Sudarshan K Vijay Naveen Jamwal |
| author_sort | Anjum Naim |
| collection | DOAJ |
| description | Context: Elevated uric acid (UA) is seen in several vascular diseases. Its significance as a prognostic marker in patients undergoing percutaneous coronary intervention (PCI) is unknown.
Aims: The aim of this study was to evaluate the association between elevated UA and major adverse cardiovascular events (MACE) at 1 year in patients undergoing PCI.
Settings and Design: This was a prospective, observational, single-center study.
Subjects and Methods: Patients undergoing PCI were categorized into hyperuricemic (HU, UA >6.0 mg/dl in women and >7.0 mg/dl in men) and normouricemic (NU) groups and were observed for 1 year. The endpoint was difference in MACE (composite of deaths, nonfatal myocardial infarction, stroke, and target vessel revascularization) at 1 year between the two groups. The secondary endpoints were the difference in Killip class at presentation, angiographic severity of coronary artery disease (CAD), cardiac arrhythmias, and congestive heart failure (CHF) between the two groups.
Results: A total of 215 patients (107 in HU arm and 108 in NU arm) were recruited. Patients in the HU arm were older, had higher frequency of multivessel CAD (93.5% vs. 79.6%, P < 0.05) and complex coronary lesions (98.1% vs. 91.7%, P < 0.05). MACE at 1 year were more frequent in the HU arm compared to the NU arm (21.5% vs. 6.5%, P < 0.05). New-onset atrial fibrillation (AF) (11.2% vs. 3.7%, P < 0.05) and CHF (13.1% vs. 4.6%, P < 0.05) were also more frequent in the HU arm versus the NU arm.
Conclusions: Elevated serum UA level in patients undergoing PCI was associated with angiographically more severe and multivessel CAD, a higher frequency of MACE, CHF, new-onset AF, and a higher mortality than those having normal UA levels. |
| first_indexed | 2024-04-12T23:45:03Z |
| format | Article |
| id | doaj.art-94fad4b77ad441f683696a4a281a8e6e |
| institution | Directory Open Access Journal |
| issn | 2321-449X |
| language | English |
| last_indexed | 2024-04-12T23:45:03Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Heart India |
| spelling | doaj.art-94fad4b77ad441f683696a4a281a8e6e2022-12-22T03:11:53ZengWolters Kluwer Medknow PublicationsHeart India2321-449X2022-01-01102747910.4103/heartindia.heartindia_12_22The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary interventionAnjum NaimAshish JhaAmresh Kumar SinghBhuwan Chandra TiwariSudarshan K VijayNaveen JamwalContext: Elevated uric acid (UA) is seen in several vascular diseases. Its significance as a prognostic marker in patients undergoing percutaneous coronary intervention (PCI) is unknown. Aims: The aim of this study was to evaluate the association between elevated UA and major adverse cardiovascular events (MACE) at 1 year in patients undergoing PCI. Settings and Design: This was a prospective, observational, single-center study. Subjects and Methods: Patients undergoing PCI were categorized into hyperuricemic (HU, UA >6.0 mg/dl in women and >7.0 mg/dl in men) and normouricemic (NU) groups and were observed for 1 year. The endpoint was difference in MACE (composite of deaths, nonfatal myocardial infarction, stroke, and target vessel revascularization) at 1 year between the two groups. The secondary endpoints were the difference in Killip class at presentation, angiographic severity of coronary artery disease (CAD), cardiac arrhythmias, and congestive heart failure (CHF) between the two groups. Results: A total of 215 patients (107 in HU arm and 108 in NU arm) were recruited. Patients in the HU arm were older, had higher frequency of multivessel CAD (93.5% vs. 79.6%, P < 0.05) and complex coronary lesions (98.1% vs. 91.7%, P < 0.05). MACE at 1 year were more frequent in the HU arm compared to the NU arm (21.5% vs. 6.5%, P < 0.05). New-onset atrial fibrillation (AF) (11.2% vs. 3.7%, P < 0.05) and CHF (13.1% vs. 4.6%, P < 0.05) were also more frequent in the HU arm versus the NU arm. Conclusions: Elevated serum UA level in patients undergoing PCI was associated with angiographically more severe and multivessel CAD, a higher frequency of MACE, CHF, new-onset AF, and a higher mortality than those having normal UA levels.http://www.heartindia.net/article.asp?issn=2321-449X;year=2022;volume=10;issue=2;spage=74;epage=79;aulast=Naimangiographic severity of coronary artery diseasecongestive heart failurehyperuricemiamajor adverse cardiovascular eventsnew-onset atrial fibrillation |
| spellingShingle | Anjum Naim Ashish Jha Amresh Kumar Singh Bhuwan Chandra Tiwari Sudarshan K Vijay Naveen Jamwal The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention Heart India angiographic severity of coronary artery disease congestive heart failure hyperuricemia major adverse cardiovascular events new-onset atrial fibrillation |
| title | The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention |
| title_full | The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention |
| title_fullStr | The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention |
| title_full_unstemmed | The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention |
| title_short | The association of serum uric acid and 1-year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention |
| title_sort | association of serum uric acid and 1 year major adverse cardiovascular events in patients undergoing percutaneous coronary intervention |
| topic | angiographic severity of coronary artery disease congestive heart failure hyperuricemia major adverse cardiovascular events new-onset atrial fibrillation |
| url | http://www.heartindia.net/article.asp?issn=2321-449X;year=2022;volume=10;issue=2;spage=74;epage=79;aulast=Naim |
| work_keys_str_mv | AT anjumnaim theassociationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT ashishjha theassociationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT amreshkumarsingh theassociationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT bhuwanchandratiwari theassociationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT sudarshankvijay theassociationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT naveenjamwal theassociationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT anjumnaim associationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT ashishjha associationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT amreshkumarsingh associationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT bhuwanchandratiwari associationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT sudarshankvijay associationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention AT naveenjamwal associationofserumuricacidand1yearmajoradversecardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention |